|
gptkbp:instanceOf
|
gptkb:chemical_compound
opioid
|
|
gptkbp:agonist_of
|
gptkb:delta-opioid_receptor
|
|
gptkbp:binding_affinity_(delta-opioid_receptor)
|
high
|
|
gptkbp:binding_affinity_(kappa-opioid_receptor)
|
low
|
|
gptkbp:binding_affinity_(mu-opioid_receptor)
|
low
|
|
gptkbp:CASNumber
|
112811-59-3
|
|
gptkbp:chemicalFormula
|
C22H26N2O2
|
|
gptkbp:developedBy
|
gptkb:SRI_International
|
|
gptkbp:effect
|
analgesic
convulsant
antidepressant-like
anxiolytic-like
increases locomotor activity in rodents
produces antidepressant-like effects in animal models
|
|
gptkbp:hasSMILES
|
C=CCN1CCN(CC1C2=CC=CC=C2)CC3=CC=CC=C3C(=O)N
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
SNC80
|
|
gptkbp:IUPACName
|
(–)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)benzyl]benzamide
|
|
gptkbp:legalStatus
|
uncontrolled (most countries)
|
|
gptkbp:molecularWeight
|
350.46 g/mol
|
|
gptkbp:PubChem_CID
|
5361222
CHEMBL26713
|
|
gptkbp:relatedTo
|
gptkb:DPDPE
BW373U86
UFP-512
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
intraperitoneal
|
|
gptkbp:sideEffect
|
seizures (in high doses)
|
|
gptkbp:studiedBy
|
pharmacology of delta-opioid receptors
|
|
gptkbp:UNII
|
6Q6X5Q2F0T
|
|
gptkbp:bfsParent
|
gptkb:delta-opioid_receptor
|
|
gptkbp:bfsLayer
|
7
|